NCT06161311

Brief Summary

Myopia has become a world concern and its prevalence has increased in recent decades. Myopic defocus has been applied for slowing down the axial elongation and myopia progression, which is mainly based on the theory of simultaneous competing defocus and peripheral optics. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses impose myopic defocus in the central or peripheral retina, with myopia progression being retarded by 50% to 60%. However, the optimal amount of myopic defocus has not yet been determined. Relative peripheral refraction (RPR) is used to indicate the difference between peripheral refraction and central refraction. Previous studies showed that retinal shape determined RPR, and baseline RPR may influence the myopia control efficacy using DIMS lenses on myopic children. It is still unclear if any other unknown factor influenced the final myopia control outcome in these young children with myopic RPR at baseline. Unlike our previous study8 that bias on hyperopic RPR children (myopic RPR, n = 27; hyperopic RPR, n = 52), this study is a case-control study with the same sample size for each RPR group. We will also include younger children who are more prone to have myopic RPR and develop high myopia. The results should provide new insight into the myopia control strategy in early-onset myopic children. In the current study, we will investigate the influence of baseline RPR in myopia retardation using DIMS lenses among young myopic children. This will ba a 1-year prospective clinical trial. Through G\*Power (version 3.1.9.6) calculation, 80 healthy myopic subjects (40 myopic RPR vs 40 hyperopic RPR) aged 5-9 years should be needed. After screened by inclusion criteria, eligible participants will be assigned to wear DIMS lenses for 1 year (12 months, 8 hour per day, 7 days per week). This study includes 5 visits: Visit 1: baseline, Visit 2: lens dispensing, Visit 3: 2-week follow-up, Visit 4: 6-month follow-up, and Visit 5: 12-month follow-up. All eye examinations will be carried out in the Optometry Research Centre (A137), the School of Optometry, the Hong Kong Polytechnic University. The main data collection, including refractive error, axial length, related ocular parameters will be measured at baseline, 6-month and 1-year visits. At the lens dispensing and 2-week follow-up visits, vision acuity testing and computer scanning of posterior eyes will be measured. New DIMS lens will be replaced and upgraded if the equivalent sphere of refraction (SER) is changed or visual acuity change. The following data will be statistically analyzed. The primary outcome data include the difference in change in SER with cycloplegia between the myopic and hyperopic RPR from the baseline over 12 months of treatment. Secondary outcomes data include the changes in axial length, peripheral refraction, relative peripheral refraction, the amplitude of accommodation, lag of accommodation, corneal curvature, phoria and stereoacuity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 7, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2025

Completed
Last Updated

October 2, 2024

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

November 30, 2023

Last Update Submit

October 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cycloplegic refractive error

    Refractive error measured after instillation of cycloplegia

    Baseline; 2 weeks, 6 months and 12 months post-treatment

Secondary Outcomes (5)

  • Axial length

    Baseline; 2 weeks, 6 months and 12 months post-treatment

  • Peripheral refraction

    Baseline; 2 weeks, 6 months and 12 months post-treatment

  • Amplitude and lag of accommodation

    Baseline; 2 weeks, 6 months and 12 months post-treatment

  • Corneal curvature

    Baseline; 2 weeks, 6 months and 12 months post-treatment

  • Phoria and stereoacuity

    Baseline; 2 weeks, 6 months and 12 months post-treatment

Study Arms (2)

Myopic RPR group

ACTIVE COMPARATOR

Patients with myopic relative peripheral refraction

Device: DIMS lenses

Hyperopic RPR group

ACTIVE COMPARATOR

Patients with hyperopic relative peripheral refraction

Device: DIMS lenses

Interventions

Defocus incorporated multiple segments lenses, which use induce peripheral myopic defocus to control for myopia development in children

Hyperopic RPR groupMyopic RPR group

Eligibility Criteria

Age6 Years - 9 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age at enrolment: 6-9 years
  • Spherical equivalent refraction (SER): -0.75 to -5.00 Diopters (D)
  • Astigmatism: -1.50 D or less
  • Anisometropia: 1.50 D or less
  • Spectacle best-corrected monocular visual acuity (VA): 0.00 logMAR or better

You may not qualify if:

  • Ocular and systemic abnormalities might affect visual functions or refractive development
  • Prior use of any drugs or optical devices of myopia control treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Optometry Research Clinic

Hong Kong, Hong Kong, nol, Hong Kong

RECRUITING

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Central Study Contacts

Tsz Wing Leung, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 7, 2023

Study Start

December 1, 2023

Primary Completion

April 3, 2025

Study Completion

April 3, 2025

Last Updated

October 2, 2024

Record last verified: 2023-11

Locations